Interestingly, there were more samples with TP53 mutation in low SASP Score group (54.76%) than high SASP Score group (34.29%) (Fig. 2E), indicating a potential context-dependent role of p53 in regulating glioma senescence. This evidence concerns the gene TP53 and central nervous system cancer.